US EditionPublished • loading... • Updated
Biotech: in Judicial Reform, Poxel Outlines Its Rebound Strategy
Summary by latribune.fr
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
In the middle of the summer, the Lyon biotech, Poxel, presented the roadmap that will allow it to bounce back. Shareholders will have to vote on a number of measures on December 11th to confirm it.
The Court of Judicial Discipline (TDJ), created after the reform of the judiciary, began operating a few months ago and already imposed its first sanctions: two judges investigated on the basis of complaints from the Attorney General's Office (FGR) and the federal government for issuing decisions considered contrary to their interests. For specialists, these measures open the door to serious risks to judicial independence.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
